Pages that link to "Q34063503"
Jump to navigation
Jump to search
The following pages link to Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer (Q34063503):
Displaying 50 items.
- Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer (Q24240739) (← links)
- Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer (Q24245085) (← links)
- Targeted Therapy in Biliary Tract Cancers (Q26798443) (← links)
- Advances in systemic therapy for advanced pancreatobiliary malignancies (Q26822703) (← links)
- Metastatic pancreatic cancer: Is there a light at the end of the tunnel? (Q28082919) (← links)
- A phase II trial of marimastat in advanced pancreatic cancer (Q28366568) (← links)
- Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades (Q30300756) (← links)
- Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials (Q30318857) (← links)
- Alternative methods of interpreting quality of life data in advanced gastrointestinal cancer patients (Q30665974) (← links)
- Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data (Q31033443) (← links)
- Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma (Q33212427) (← links)
- Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer (Q33214444) (← links)
- Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report (Q33250432) (← links)
- Technology insight: Photodynamic therapy for cholangiocarcinoma (Q33252543) (← links)
- Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). (Q33327923) (← links)
- A phase II study of gemcitabine in gallbladder carcinoma (Q33340368) (← links)
- A comprehensive update on the use of chemotherapy for metastatic pancreatic adenocarcinoma (Q33342822) (← links)
- Phase II trial of a 24-hour infusion of gemcitabine in previously untreated patients with advanced pancreatic adenocarcinoma (Q33357700) (← links)
- Salvage chemotherapy with mitomycin, docetaxel, and irinotecan (MDI regimen) in metastatic pancreatic adenocarcinoma: a phase I and II trial (Q33364008) (← links)
- The efficacy of epirubicin, cisplatin, uracil/tegafur, and leucovorin in patients with advanced biliary tract carcinoma (Q33365804) (← links)
- Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer (Q33366682) (← links)
- Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study (Q33367224) (← links)
- Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas (Q33369849) (← links)
- Raltitrexed-eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer. (Q33370390) (← links)
- Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer (Q33371306) (← links)
- EGFR expression in gallbladder carcinoma in North America (Q33372792) (← links)
- Combined chemotherapy of irinotecan and low-dose cisplatin (I/low-P) against metastatic biliary tract cancer (Q33372825) (← links)
- Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer. (Q33381016) (← links)
- Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study (Q33383423) (← links)
- Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers. (Q33384257) (← links)
- Pilot study of irinotecan/oxalipltin (IROX) combination chemotherapy for patients with gemcitabine- and 5-fluorouracil- refractory pancreatic cancer (Q33384513) (← links)
- A phase II study of gemcitabine and oxaliplatin (Oxigem) in unresectable gall bladder cancer (Q33385243) (← links)
- Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial (Q33385654) (← links)
- Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study (Q33385766) (← links)
- Gemcitabine versus gemcitabine combined with cisplatin treatment locally advanced or metastatic pancreatic cancer: a retrospective analysis (Q33385864) (← links)
- The cisplatin, epirubicin, 5-fluorouracil, gemcitabine (PEFG) regimen in advanced biliary tract adenocarcinoma (Q33388402) (← links)
- Gemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution study (Q33391003) (← links)
- Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study (Q33394065) (← links)
- Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting (Q33394190) (← links)
- A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients (Q33399656) (← links)
- Outcome of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) chemotherapy and analysis of prognostic factors in patients with refractory advanced biliary tract cancer (Q33402129) (← links)
- Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy (Q33417019) (← links)
- A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002). (Q33419175) (← links)
- Is concomitant radiotherapy necessary with gemcitabine-based chemotherapy in pancreatic cancer? (Q33419384) (← links)
- Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer (Q33420043) (← links)
- Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma (Q33428348) (← links)
- A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract (Q33430668) (← links)
- Treatment of advanced pancreatic carcinoma with a combination of protracted infusional 5-fluorouracil and weekly carboplatin: A Mid-Atlantic Oncology Program study (Q33499869) (← links)
- Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin (Q33503141) (← links)
- Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study (Q33506777) (← links)